Immunopathology in ocular toxoplasmosis: facts and clues

Although parasite-mediated host cell lysis is deemed to be an important cause of tissue destruction in ocular toxoplasmosis (OT), the severity of the disease is probably correlated with hypersensitivity and inflammation. Notwithstanding, the mechanisms that regulate the inflammatory process in recurrent OT are poorly understood. Recent evidence has identified interleukin (IL) 17 as a marker for disease severity. The ocular and cerebral presence of this cytokine is generally associated with the induction of autoimmune responses in the brain and the eye. Indeed, there are indications that autoimmunity may contribute to clinical variability in the activity of OT. IL-23, which induces the proliferation of IL-17-producing cells and IL-27, which is a counterplayer to IL-17, may regulate T(H)-1-cell-mediated responses in OT. The importance of these cytokines in experimental models of uveitis and encephalitis has been recently reported. CD25(+) regulatory T-cells may control the local inflammatory response and protect the host against collateral inflammatory tissue damage. The responses of these cells to OT may be suitably tailored to cope with either an acquired or a congenital aetiology. Knowledge relating to immunoreactivity in OT has grown impressively during the past few years. Its characteristic and variable features have been identified and the potential relevance of autoimmunity has been assessed. In light of this knowledge, potential future treatment options have been considered.

Saved in:
Bibliographic Details
Main Authors: Garweg,Justus G, Candolfi,Ermanno
Format: Digital revista
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2009
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000200014
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0074-02762009000200014
record_format ojs
spelling oai:scielo:S0074-027620090002000142009-05-05Immunopathology in ocular toxoplasmosis: facts and cluesGarweg,Justus GCandolfi,Ermanno ocular toxoplasmosis acquired toxoplasmosis congenitally contracted toxoplasmosis experimental autoimmune uveitis cytokines chemokines Although parasite-mediated host cell lysis is deemed to be an important cause of tissue destruction in ocular toxoplasmosis (OT), the severity of the disease is probably correlated with hypersensitivity and inflammation. Notwithstanding, the mechanisms that regulate the inflammatory process in recurrent OT are poorly understood. Recent evidence has identified interleukin (IL) 17 as a marker for disease severity. The ocular and cerebral presence of this cytokine is generally associated with the induction of autoimmune responses in the brain and the eye. Indeed, there are indications that autoimmunity may contribute to clinical variability in the activity of OT. IL-23, which induces the proliferation of IL-17-producing cells and IL-27, which is a counterplayer to IL-17, may regulate T(H)-1-cell-mediated responses in OT. The importance of these cytokines in experimental models of uveitis and encephalitis has been recently reported. CD25(+) regulatory T-cells may control the local inflammatory response and protect the host against collateral inflammatory tissue damage. The responses of these cells to OT may be suitably tailored to cope with either an acquired or a congenital aetiology. Knowledge relating to immunoreactivity in OT has grown impressively during the past few years. Its characteristic and variable features have been identified and the potential relevance of autoimmunity has been assessed. In light of this knowledge, potential future treatment options have been considered.info:eu-repo/semantics/openAccessInstituto Oswaldo Cruz, Ministério da SaúdeMemórias do Instituto Oswaldo Cruz v.104 n.2 20092009-03-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000200014en10.1590/S0074-02762009000200014
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Garweg,Justus G
Candolfi,Ermanno
spellingShingle Garweg,Justus G
Candolfi,Ermanno
Immunopathology in ocular toxoplasmosis: facts and clues
author_facet Garweg,Justus G
Candolfi,Ermanno
author_sort Garweg,Justus G
title Immunopathology in ocular toxoplasmosis: facts and clues
title_short Immunopathology in ocular toxoplasmosis: facts and clues
title_full Immunopathology in ocular toxoplasmosis: facts and clues
title_fullStr Immunopathology in ocular toxoplasmosis: facts and clues
title_full_unstemmed Immunopathology in ocular toxoplasmosis: facts and clues
title_sort immunopathology in ocular toxoplasmosis: facts and clues
description Although parasite-mediated host cell lysis is deemed to be an important cause of tissue destruction in ocular toxoplasmosis (OT), the severity of the disease is probably correlated with hypersensitivity and inflammation. Notwithstanding, the mechanisms that regulate the inflammatory process in recurrent OT are poorly understood. Recent evidence has identified interleukin (IL) 17 as a marker for disease severity. The ocular and cerebral presence of this cytokine is generally associated with the induction of autoimmune responses in the brain and the eye. Indeed, there are indications that autoimmunity may contribute to clinical variability in the activity of OT. IL-23, which induces the proliferation of IL-17-producing cells and IL-27, which is a counterplayer to IL-17, may regulate T(H)-1-cell-mediated responses in OT. The importance of these cytokines in experimental models of uveitis and encephalitis has been recently reported. CD25(+) regulatory T-cells may control the local inflammatory response and protect the host against collateral inflammatory tissue damage. The responses of these cells to OT may be suitably tailored to cope with either an acquired or a congenital aetiology. Knowledge relating to immunoreactivity in OT has grown impressively during the past few years. Its characteristic and variable features have been identified and the potential relevance of autoimmunity has been assessed. In light of this knowledge, potential future treatment options have been considered.
publisher Instituto Oswaldo Cruz, Ministério da Saúde
publishDate 2009
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000200014
work_keys_str_mv AT garwegjustusg immunopathologyinoculartoxoplasmosisfactsandclues
AT candolfiermanno immunopathologyinoculartoxoplasmosisfactsandclues
_version_ 1756383626843389952